Literature DB >> 12032976

Satisfaction with access to health care among injection drug users, other drug users, and nonusers.

Dale D Chitwood1, Mary Comerford, H Virginia McCoy.   

Abstract

This article examines the satisfaction of users of cocaine and/or opiates and non-drug users with access to the health care system. Data were obtained from a sample of 1,477 injection drug users, non-injection drug users, and non-drug users recruited from neighborhoods with high drug use. Multiple regression examined the relationship between satisfaction with access to health care and demographic, health status and health care utilization, ability to pay, and alcohol and drug use variables. Age, ethnicity, health status, having received health care in the last 12 months, not having received health care when needed, having received preventive health care, health insurance, and drug use were independently associated with satisfaction. Injection drug users and non-injection drug users were less satisfied with access to health care. The article discusses strategies to improve health care delivery to drug users.

Entities:  

Mesh:

Year:  2002        PMID: 12032976     DOI: 10.1007/bf02287705

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  15 in total

1.  Bacterial infections and skin cleaning prior to injection among intravenous drug users.

Authors:  D Vlahov; M Sullivan; J Astemborski; K E Nelson
Journal:  Public Health Rep       Date:  1992 Sep-Oct       Impact factor: 2.792

2.  Behavioral consequences of consumer dissatisfaction with medical care.

Authors:  J E Ware; A R Davies
Journal:  Eval Program Plann       Date:  1983

3.  Variation in health service use among HIV-infected patients.

Authors:  V Mor; J A Fleishman; M Dresser; J Piette
Journal:  Med Care       Date:  1992-01       Impact factor: 2.983

4.  Health status and satisfaction with health care: results from the medical outcomes study.

Authors:  G N Marshall; R D Hays; R Mazel
Journal:  J Consult Clin Psychol       Date:  1996-04

5.  A framework for the study of access to medical care.

Authors:  L A Aday; R Andersen
Journal:  Health Serv Res       Date:  1974       Impact factor: 3.402

Review 6.  The major medical complications of heroin addiction.

Authors:  D B Louria; T Hensle; J Rose
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

Review 7.  The medical sequelae of narcotic addiction.

Authors:  C E Cherubin
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

8.  Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers.

Authors:  D D Chitwood; D C McBride; M T French; M Comerford
Journal:  Subst Use Misuse       Date:  1999 Mar-Apr       Impact factor: 2.164

Review 9.  Medical care for injection-drug users with human immunodeficiency virus infection.

Authors:  P G O'Connor; P A Selwyn; R S Schottenfeld
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

10.  Cocaine-related medical problems: consecutive series of 233 patients.

Authors:  S L Brody; C M Slovis; K D Wrenn
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

View more
  15 in total

1.  Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Authors:  Alexandra Lutnick; Patricia Case; Alex H Kral
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

2.  Correlates of Cervical Cancer Screening Among Adult Latino Women: A 5-Year Follow-Up.

Authors:  Patria Rojas; Tan Li; Gira J Ravelo; Christyl Dawson; Mariana Sanchez; Alicia Sneij; Weize Wang; Mariano Kanamori; Elena Cyrus; Mario R De La Rosa
Journal:  World Med Health Policy       Date:  2017-06-12

3.  Use of Mental Health Services among People with Co-Occurring Disorders and other Mental Health co-morbidities: Employing the Behavioral Model of Vulnerable Populations.

Authors:  La Fleur F Small
Journal:  Ment Health Subst Use       Date:  2010

4.  A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center.

Authors:  Michelle A Lally; Ryan MacNevin; Ziad Sergie; Robert Hitt; Melissa DiSpigno; Carly Cenedella; Michael D Stein
Journal:  AIDS Patient Care STDS       Date:  2005-05       Impact factor: 5.078

5.  Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic and HIV test site screening programs.

Authors:  Karen E Mark; Paula J Murray; David B Callahan; Robert A Gunn
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

6.  Differences in HIV risk behavior of injection drug users in New York City by health care setting.

Authors:  A K Turner; K Harripersaud; N D Crawford; A V Rivera; C M Fuller
Journal:  AIDS Care       Date:  2013-03-01

7.  Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.

Authors:  Alia A Al-Tayyib; Hanne Thiede; Richard D Burt; Stephen Koester
Journal:  Prev Sci       Date:  2015-02

8.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

9.  Healthcare Contacts Regarding Circulatory Conditions among Swedish Patients in Opioid Substitution Treatment, with and without On-Site Primary Healthcare.

Authors:  Eric Bäckström; Katja Troberg; Anders Håkansson; Disa Dahlman
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

10.  Health and oral health care needs and health care-seeking behavior among homeless injection drug users in San Francisco.

Authors:  Jonathan Leserman Robbins; Lynn Wenger; Jennifer Lorvick; Caroline Shiboski; Alex H Kral
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.